Ultrasound Guided Ureteroscopy and Ureteric Stones

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-01

Study Completion Date

2020-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The prevalence of urolithiasis is steadily increasing with an estimation of 1 out of 11 people in the United States. The prevalence of calculi in Afro-Asian region including Arab Republic of Egypt ranges from 4% to 20%. Ureteroscopy is one of the first line treatments for definitive management of ureteric stones. Conventional ureteroscopy relies on intraoperative fluoroscopy for visualization and guidance, exposing the patient, surgeon and operating room staff to ionizing radiation. To minimize the hazards of ionizing radiation there has been a trend toward radiation free alternative imaging modalities . Ultrasound provides an excellent alternative for upper urinary tract imaging because it is radiation free, rapid, portable and allows excellent visualization of the renal pelvis and calyces. There is increasing awareness and concern about the clinical use of ionizing radiation and the need to decrease exposure of patients and medical professionals. Ultrasound guided ureteroscopy in pregnant females and children- in whom fluoroscopy is to be minimized or avoided when possible - has been reported.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones

NCT04071340

Renal Stone

COMPLETED

Flexible Ureteroscopy Versus Extracorporeal Shock Wave Lithotripsy

NCT07193940

Kidney Stones

NOT_YET_RECRUITING NA

Ultra Mini Percutaneous Nephrolithotomy VS Stented Extracorporeal Shock Wave Lithotripsy for Stone Management

NCT05697341

Renal Stone

COMPLETED NA

ESWL vs URS in Management of Upper Third Ureteric Calculi

NCT03559738

Ureteral Stones

COMPLETED

Shock Wave Lithotripsy Using Fluoroscopic Versus Ultrasonic Localization

NCT05413603

Stone, Kidney Child, Only

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ureteric Stone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standardized ureteroscopy group

Group Type OTHER

ureteroscopy

Intervention Type PROCEDURE

The patients will be subjected to rigid ureteroscopy

Ultrasonography ureteroscopy group

Group Type OTHER

ureteroscopy

Intervention Type PROCEDURE

The patients will be subjected to rigid ureteroscopy

Ultrasonography

Intervention Type RADIATION

The patients will be subjected to Ultrasonography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ureteroscopy

The patients will be subjected to rigid ureteroscopy

Intervention Type PROCEDURE

Ultrasonography

The patients will be subjected to Ultrasonography

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with single symptomatic lower third ureteric radio-opaque stones indicated for endoscopic treatment.
2. Age group 18 years old or above.
3. Stone size 15 mm or less.

Exclusion Criteria

1. Patients with bilateral ureteric stones
2. Ureteric congenital anomalies e.g. double ureter and ectopic ureter.
3. Previously failed ureteroscopy or previous ureteroneocystostomy.

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No